RecruitingNCT06694415

Determining Paediatric Usual Values for Hormones Dosages by LC-MS/MS

Determining Paediatric Usual Values for Hormones Dosages by Mass Spectrometry


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

1,500 participants

Start Date

Jan 2, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Liquid chromatography coupled with mass spectrometry (LC-MS/MS) is now the method of choice for steroid hormone analysis, as it enables analyses to be carried out on small-volume samples on a wider range of hormones, with improved specificity compared with immunoassays. Hormone assays currently face a twofold problem: on the one hand, immunoassays are highly dependent on the synthesis of antibody kits manufactured by companies with immunotechnology expertise; on the other hand, these immunoassays may require the use of radioactive products for quantification, generating considerable risks for both staff and environment. There are international recommendations from expert societies (World Anti-Doping Agency, Endocrine society) to develop new, more reliable assay methods, such as LC-MS/MS, and to phase out immuno- and radioassay techniques. However, changing measurement methods requires the development of reference values to maintain and optimize the management of patients. The aim of this project is therefore to establish usual values in a paediatric population, through collaboration between the clinical departments of the APHP and the METOMICS laboratory, which has mastered the technology.


Eligibility

Max Age: 20 Years

Inclusion Criteria2

  • Male or female patient ≤ 20 years old
  • undergoing a blood sample as part of their pathology routine follow-up

Exclusion Criteria2

  • Any identified or suspected endocrine pathology
  • Any acute infectious or inflammatory disorder

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Service d'Endocrinologie Pédiatrique-Explorations Fonctionnelles Hôpital Trousseau

Paris, Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06694415


Related Trials